Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Viatris Inc

Viatris Inc

VTRS · NASDAQ
VTRS · NASDAQ

Next Earnings: 05 Nov 2026

16.95
USD0.301.80%

Latest News

    @Reuters
    Reuters

    UK watchdog says Theramex-Viatris deal raises competition concerns https://t.co/FZiF8gi2io https://t.co/ntQ34DysLU

      SeekingAlpha

      Viatris- Theramex deal for women's care products raises antitrust concerns in U.K.

        MarketWatch

        Viatris makes progress on Ozempic patent challenge

          SeekingAlpha

          Viatris receives offer to divest all of it's over the counter business

            Moneycontrol

            Viatris sells API & women's healthcare business in India for $1.2 billion - Moneycontrol

              SeekingAlpha

              Viatris in talks to sell European OTC assets to CVC unit - report

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              16.66USD
              17.05USD

              52 Week Range

              9.43USD
              18.39USD

              Market Cap

              18.96BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US92556V1061

              CUSIP

              92556V106

              Sector

              Healthcare

              Industry

              Drug Manufacturers - Specialty & Generic

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              1.05

              Book Value

              12.59

              Dividend Share

              0.48

              Dividend Yield

              2.88%

              Earnings Share

              -0.37

              Wall Street Target Price

              18.67

              EPS Estimate Current Year

              2.51

              EPS Estimate Next Year

              2.66

              EPS Estimate Current Quarter

              0.5998

              EPS Estimate Next Quarter

              0.6374

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              14,737,300,480

              Gross Profit TTM

              5,940,199,936

              EBITDA

              4,292,499,968

              Profit Margin

              -2.79%

              Return On Assets TTM

              2.67%

              Return On Equity TTM

              -2.75%

              Revenue Per Share TTM

              12.715

              Qtly Revenue Growth YOY

              4.90%

              Diluted Eps TTM

              -0.37

              Qtly Earnings Growth YOY

              -70.60%

              Valuation

              Trailing PE

              0.00

              Forward PE

              6

              Price Sales TTM

              1.2977

              Price Book MRQ

              1.3415

              Enterprise Value Revenue

              2

              Enterprise Value EBITDA

              11

              Peers analysis

              • MERCK Kommanditgesellschaft auf Aktien
                MKGAFMERCK Kommanditgesellschaft auf Aktien

                157.05

                3.37%
              • Ha
                HLNCFHaleon plc

                4.59

                0.22%
              • Ga
                GDERFGalderma Group AG

                185.50

                0.00%
              • Takeda Pharmaceutical Co. Ltd.
                TKPHFTakeda Pharmaceutical Co. Ltd.

                36.20

                0.00%
              • Ji
                JHPCYJiangsu Hengrui Pharmaceuticals Co.,Ltd

                11.50

                -4.41%
              • Teva Pharmaceutical Industries Limited
                TEVJFTeva Pharmaceutical Industries Limited

                38.53

                -1.83%
              • Teva Pharma Industries Ltd ADR
                TEVATeva Pharma Industries Ltd ADR

                38.53

                -1.67%
              • Takeda Pharmaceutical Co Ltd ADR
                TAKTakeda Pharmaceutical Co Ltd ADR

                18.64

                -0.43%
              • GA
                GALDYGALDERMA GROUP AG

                37.02

                -0.42%
              • Merck KGaA ADR
                MKKGYMerck KGaA ADR

                30.11

                -0.17%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Viatris stock price today?

              What is Viatris stock ticker?

              Is VTRS stock price going up?

              What is the analyst recommendation for VTRS?

              What is VTRS market cap?

              Does VTRS release financial reports?

              When is VTRS next earnings date?

              What were VTRS Earnings for the last quarter?

              What was VTRS Revenue for the last quarter?

              What was VTRS Net Income for the last quarter?

              Does VTRS pay dividends?

              How many employees does VTRS have?

              What is VTRS EBITDA?

              How to buy VTRS stocks?

              Should I invest in VTRS stock?

              What are you waiting for?Get started today
              ©
               2026 
              All rights reserved

              Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.

              Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.

              Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.